In conclusion, this meta-analysis seemed to exclude any relevant short-term effect of DPP4-inhibitors on the incidence of cancer and suggested a possible protection from MACE, but the result should be interpreted with caution, as those events were not the principal endpoints. This evidence concerns the gene DPP4 and cancer.